ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADTX ADiTx Therapeutics

交易中 02-04 13:46:53 EST

0.6580

-0.0623

-8.65%

最高0.7629	最低0.6319	成交量14.40万
今开0.7300	昨收0.7203	日振幅18.19%
总市值116.86万	流通市值116.86万	总股本177.60万
成交额9.67万	换手率8.11%	流通股本177.60万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADTX","market":"US","secType":"STK","nameCN":"ADiTx Therapeutics","latestPrice":0.658,"timestamp":1770230766853,"preClose":0.7203,"halted":0,"volume":144037,"delay":0,"changeRate":-0.08649173955296406,"floatShares":1776000,"shares":1776000,"eps":-4919.3423,"marketStatus":"交易中","change":-0.0623,"latestTime":"02-04 13:46:53 EST","open":0.73,"high":0.7629,"low":0.6319,"amount":96692.68050502,"amplitude":0.181869,"askPrice":0.6721,"askSize":100,"bidPrice":0.6516,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-4919.3423,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770238800000},"marketStatusCode":2,"adr":0,"listingDate":1593489600000,"exchange":"NASDAQ","adjPreClose":0.7203,"preHourTrading":{"tag":"盘前","latestPrice":0.749,"preClose":0.7203,"latestTime":"09:29 EST","volume":3300,"amount":2439.31644,"timestamp":1770215389116,"change":0.0287,"changeRate":0.039845,"amplitude":0.124531},"postHourTrading":{"tag":"盘后","latestPrice":0.7299,"preClose":0.7203,"latestTime":"19:58 EST","volume":4216,"amount":3077.9308,"timestamp":1770166712927,"change":0.0096,"changeRate":0.013328,"amplitude":0.053866},"volumeRatio":0.960741,"impliedVol":6.3423,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADTX","defaultTab":"news","newsList":[{"id":"1122736896","title":"Aditxt发布Bitxbio™增长愿景的最新进展、计划中的数字资产国库、Pearsanta的IPO计划和Evofem的国家上市恢复计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1122736896","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122736896?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:01","pubTimestamp":1763470887,"startTime":"0","endTime":"0","summary":"Aditxt发布了关于其Bitxbio™增长愿景的最新进展，包括计划中的数字资产国库、Pearsanta的IPO计划以及Evofem恢复国家上市的计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"gpt_icon":0},{"id":"1162019859","title":"Aditxt, Inc.（纳斯达克：ADTX）宣布于2025年11月3日交易开始时实施1股换113股的反向股拆分","url":"https://stock-news.laohu8.com/highlight/detail?id=1162019859","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162019859?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:32","pubTimestamp":1761769974,"startTime":"0","endTime":"0","summary":"Aditxt, Inc.（纳斯达克：ADTX）宣布于2025年11月3日交易开始时实施1股换113股的反向股拆分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"gpt_icon":0},{"id":"1194082919","title":"Aditxt子公司Pearsanta启动首个人体研究的招募，研究针对影响全球1.9亿女性的子宫内膜异位症的血液检测，全球市场规模达14.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194082919","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194082919?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:30","pubTimestamp":1761568218,"startTime":"0","endTime":"0","summary":"Aditxt子公司Pearsanta启动首个人体研究的招募，研究针对影响全球1.9亿女性的子宫内膜异位症的血液检测，全球市场规模达14.5亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADTX"],"gpt_icon":0},{"id":"1133028071","title":"Evofem Biosciences Inc: 向Aditxt发送终止通知，宣布行使终止合并协议的权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1133028071","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133028071?lang=zh_cn&edition=full","pubTime":"2025-10-21 06:00","pubTimestamp":1760997611,"startTime":"0","endTime":"0","summary":"Evofem Biosciences Inc: 向Aditxt发送终止通知，宣布行使终止合并协议的权利","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADTX","EVFM","BK4584","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aditxt.com","stockEarnings":[{"period":"1week","weight":-0.2558},{"period":"1month","weight":-0.1857},{"period":"3month","weight":-0.8736},{"period":"6month","weight":-0.9948},{"period":"1year","weight":-0.9998},{"period":"ytd","weight":-0.1368}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aditxt, Inc.于2017年9月28日根据特拉华州法律注册成立。该公司是一家临床前阶段的生命科学公司，致力于延长移植患者的生命和提高移植患者的生活质量。他们拥有独家全球许可证，用于将这种基于核酸的技术称为Apoptotic DNA Immunotherapy（ADi），该技术利用新的方法模仿他们的身体自然诱导对自身组织的耐受性。该公司计划开发用于器官移植，植皮和创伤愈合的ADi产品，最初的重点是皮肤移植和其他器官和组织同种异体移植。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.013912},{"month":2,"riseRate":0,"avgChangeRate":-0.192707},{"month":3,"riseRate":0.2,"avgChangeRate":-0.169474},{"month":4,"riseRate":0.2,"avgChangeRate":-0.266324},{"month":5,"riseRate":0.2,"avgChangeRate":-0.125836},{"month":6,"riseRate":0,"avgChangeRate":-0.251138},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.120854},{"month":8,"riseRate":0.166667,"avgChangeRate":0.274702},{"month":9,"riseRate":0,"avgChangeRate":-0.488285},{"month":10,"riseRate":0,"avgChangeRate":-0.418091},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.288889},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.245759}],"exchange":"NASDAQ","name":"ADiTx Therapeutics","nameEN":"ADiTx Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ADiTx Therapeutics,ADTX,ADiTx Therapeutics股票,ADiTx Therapeutics股票老虎,ADiTx Therapeutics股票老虎国际,ADiTx Therapeutics行情,ADiTx Therapeutics股票行情,ADiTx Therapeutics股价,ADiTx Therapeutics股市,ADiTx Therapeutics股票价格,ADiTx Therapeutics股票交易,ADiTx Therapeutics股票购买,ADiTx Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADiTx Therapeutics(ADTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ADiTx Therapeutics(ADTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}